US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 10.390
  • -0.220-2.07%
Close Dec 13 16:00 ET
  • 10.390
  • 0.0000.00%
Post 20:01 ET
1.00BMarket Cap-13.85P/E (TTM)

Avadel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
613.22%50.03M
2,674.33%41.5M
27.18M
27.96M
19.45M
7.01M
1.5M
0
0
0
Operating revenue
613.22%50.03M
2,674.33%41.5M
--27.18M
--27.96M
--19.45M
--7.01M
--1.5M
--0
--0
--0
Cost of revenue
5,160.68%6.16M
7,644.44%2.79M
1.52M
846K
693K
117K
36K
0
0
0
Gross profit
536.07%43.87M
2,551.78%38.72M
25.66M
27.12M
18.76M
6.9M
1.46M
0
0
0
Operating expense
5.21%44.2M
0.89%51.46M
82.67%51.69M
73.25%164.97M
88.06%43.66M
146.68%42.01M
93.59%51M
-1.15%28.3M
11.23%95.22M
0.35%23.22M
Selling and administrative expenses
3.16%40.39M
1.34%47.41M
98.72%48.62M
103.59%151.71M
143.22%41.3M
177.80%39.16M
114.54%46.78M
13.09%24.47M
8.79%74.52M
-19.24%16.98M
Research and development costs
33.49%3.8M
-4.07%4.05M
-19.90%3.07M
-35.94%13.26M
-62.17%2.36M
-2.86%2.85M
-7.00%4.22M
-45.22%3.83M
21.02%20.7M
195.50%6.24M
Operating profit
99.07%-327K
74.28%-12.74M
8.00%-26.04M
-44.78%-137.85M
-7.25%-24.9M
-106.18%-35.11M
-88.05%-49.54M
1.15%-28.3M
-11.23%-95.22M
-0.35%-23.22M
Net non-operating interest income expense
-42.57%-2.82M
-18.34%-2.72M
20.47%-2.59M
19.90%-9.89M
27.68%-2.35M
44.50%-1.98M
34.54%-2.3M
-61.58%-3.26M
-24.14%-12.34M
21.64%-3.26M
Non-operating interest expense
42.57%2.82M
18.34%2.72M
-20.47%2.59M
-19.90%9.89M
-27.68%2.35M
-44.50%1.98M
-34.54%2.3M
61.58%3.26M
24.14%12.34M
-21.64%3.26M
Other net income (expense)
-32.45%610K
109.00%1.13M
613.99%1.38M
-236.05%-13.04M
-82.55%-1.63M
74.66%903K
-267.82%-12.51M
285.58%193K
-261.98%-3.88M
-238.39%-894K
Gain on sale of security
-32.45%610K
80.74%1.13M
613.99%1.38M
116.23%87K
-52.24%-1.63M
101.56%903K
224.48%623K
285.58%193K
-122.88%-536K
-232.02%-1.07M
Special income (charges)
--0
--0
----
-292.50%-13.13M
--0
--0
-265.51%-13.13M
----
-6,411.32%-3.35M
--178K
-Less:Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
6,411.32%3.35M
---178K
-Less:Other special charges
----
----
----
--13.13M
--0
----
--13.13M
----
----
----
Income before tax
92.99%-2.54M
77.73%-14.33M
13.12%-27.25M
-44.27%-160.78M
-5.56%-28.89M
-80.24%-36.19M
-93.50%-64.34M
-2.01%-31.36M
-19.64%-111.44M
-2.71%-27.37M
Income tax
-1.12%88K
-665.56%-509K
116.03%93K
-101.93%-501K
-217.65%-100K
27.14%89K
-99.70%90K
86.58%-580K
264.55%26.03M
101.96%85K
Net income
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
Net income continuous Operations
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
Minority interest income
Net income attributable to the parent company
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
Basic earnings per share
92.68%-0.03
83.13%-0.14
37.50%-0.3
12.66%-2
34.09%-0.29
-24.24%-0.41
22.43%-0.83
-6.67%-0.48
-73.48%-2.29
-15.79%-0.44
Diluted earnings per share
92.68%-0.03
83.13%-0.14
37.50%-0.3
12.66%-2
34.09%-0.29
-24.24%-0.41
22.43%-0.83
-6.67%-0.48
-73.48%-2.29
-15.79%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 613.22%50.03M2,674.33%41.5M27.18M27.96M19.45M7.01M1.5M000
Operating revenue 613.22%50.03M2,674.33%41.5M--27.18M--27.96M--19.45M--7.01M--1.5M--0--0--0
Cost of revenue 5,160.68%6.16M7,644.44%2.79M1.52M846K693K117K36K000
Gross profit 536.07%43.87M2,551.78%38.72M25.66M27.12M18.76M6.9M1.46M000
Operating expense 5.21%44.2M0.89%51.46M82.67%51.69M73.25%164.97M88.06%43.66M146.68%42.01M93.59%51M-1.15%28.3M11.23%95.22M0.35%23.22M
Selling and administrative expenses 3.16%40.39M1.34%47.41M98.72%48.62M103.59%151.71M143.22%41.3M177.80%39.16M114.54%46.78M13.09%24.47M8.79%74.52M-19.24%16.98M
Research and development costs 33.49%3.8M-4.07%4.05M-19.90%3.07M-35.94%13.26M-62.17%2.36M-2.86%2.85M-7.00%4.22M-45.22%3.83M21.02%20.7M195.50%6.24M
Operating profit 99.07%-327K74.28%-12.74M8.00%-26.04M-44.78%-137.85M-7.25%-24.9M-106.18%-35.11M-88.05%-49.54M1.15%-28.3M-11.23%-95.22M-0.35%-23.22M
Net non-operating interest income expense -42.57%-2.82M-18.34%-2.72M20.47%-2.59M19.90%-9.89M27.68%-2.35M44.50%-1.98M34.54%-2.3M-61.58%-3.26M-24.14%-12.34M21.64%-3.26M
Non-operating interest expense 42.57%2.82M18.34%2.72M-20.47%2.59M-19.90%9.89M-27.68%2.35M-44.50%1.98M-34.54%2.3M61.58%3.26M24.14%12.34M-21.64%3.26M
Other net income (expense) -32.45%610K109.00%1.13M613.99%1.38M-236.05%-13.04M-82.55%-1.63M74.66%903K-267.82%-12.51M285.58%193K-261.98%-3.88M-238.39%-894K
Gain on sale of security -32.45%610K80.74%1.13M613.99%1.38M116.23%87K-52.24%-1.63M101.56%903K224.48%623K285.58%193K-122.88%-536K-232.02%-1.07M
Special income (charges) --0--0-----292.50%-13.13M--0--0-265.51%-13.13M-----6,411.32%-3.35M--178K
-Less:Restructuring and merger&acquisition --------------0----------------6,411.32%3.35M---178K
-Less:Other special charges --------------13.13M--0------13.13M------------
Income before tax 92.99%-2.54M77.73%-14.33M13.12%-27.25M-44.27%-160.78M-5.56%-28.89M-80.24%-36.19M-93.50%-64.34M-2.01%-31.36M-19.64%-111.44M-2.71%-27.37M
Income tax -1.12%88K-665.56%-509K116.03%93K-101.93%-501K-217.65%-100K27.14%89K-99.70%90K86.58%-580K264.55%26.03M101.96%85K
Net income 92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M
Net income continuous Operations 92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M
Minority interest income
Net income attributable to the parent company 92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M
Basic earnings per share 92.68%-0.0383.13%-0.1437.50%-0.312.66%-234.09%-0.29-24.24%-0.4122.43%-0.83-6.67%-0.48-73.48%-2.29-15.79%-0.44
Diluted earnings per share 92.68%-0.0383.13%-0.1437.50%-0.312.66%-234.09%-0.29-24.24%-0.4122.43%-0.83-6.67%-0.48-73.48%-2.29-15.79%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.